3 ms·
The system I imagine: * drug development being funded by government; * thru misc stages (research, clinical trials, certification, mfg, etc); * at every stag
by specialist 7y ago
The system I imagine:
* drug development being funded by government;
* thru misc stages (research, clinical trials, certification, mfg, etc);
* at every stage third parties (public, private, or both) bidding on time boxed rights to license drug and carry drug thru remaining stages;
* licensee paying royalties.
Earlier involvement in the most promising drugs is incentivized by allowing third parties to license earlier, taking on more of the risk, getting a better deal.
Orphaned drugs can still get some love by do gooders. In fact, government can pay (subsidize) third parties when there's no profit.
I'm a total noob, and have zero idea if this worldview has any merit.
Also, prohibit advertising and all forms of payola.
- jonlucc 7y agoWe sort of have this system, but in reverse. You're suggesting to default to government, and we currently have a default-to-private system. The US government funds basic research, basic development, and clinical trials for projects it deems important enough that will not see adoption by corporations due to a lack of profit. One example of this is ebola vaccines. If I remember correctly, the incidence of ebola is incredibly (even internationally) low, but there is a public health justification for keeping a working vaccine available. The government, mostly through NIH, will sponsor the development of these kinds of projects. This also happens sometimes with orphan diseases. The government funds more research further up the chain until it's enticing to private companies.